Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCR6 (clone R6Z0Z2E). We employs the Lentivirus (CMV-GFP-IL-10-EcoRI) vector components and the SynExpress system of the Exons Knockout/Positive feedback for a robust and sustained response against cancers.
Host
human
Target
CCR6
Clone
R6Z0Z2E
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.96
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.